May 11 (Reuters) - Britain's GSK said on Monday it signed a deal with Hong Kong-listed Sino Biopharmaceutical to expand its ...

HBV infection at birth or during early infancy can lead to lifelong health problems such as chronic liver disease and liver cancer. Newborns are at highest risk, with 90% of those infected with HBV ...

Alex Hogan is STAT’s senior multimedia producer and host of STATus Report, STAT’s weekly video series. You can follow him on Bluesky. The Centers for Disease Control and Prevention just rolled back ...

FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB ...

GSK plc GSK on Monday entered into an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group), through its ...

The marketing deal is the latest in a series of recent pacts between GSK and China-based drug companies, and could speed ...

US model study suggests a targeted hepatitis B birth-dose strategy could increase neonatal infections unless screening and ...

Federal vaccine advisers to Health Secretary Robert F. Kennedy Jr. voted in December to recommend delaying the first shot ...

Researchers found that the decision to delay the once-universal hepatitis B shot for babies will likely cause a surge in ...

For some people, their immune system can clear the hepatitis B virus with natural immunity. However, some individuals can build immunity to hepatitis B through vaccination. For some people, the ...

If someone presents you with a hepatitis B declination form, you might have some questions about it and the hepatitis B vaccine more generally. Hepatitis B is an infection of the liver due to the ...